Michael Kennedy: "We've really hit an amazing stride in terms of basket innovation, and we've really embraced some new ...
5d
GlobalData on MSNMaze Therapeutics doses first subject in Phase II AKD treatment trialMaze Therapeutics has dosed the first subject in the Phase II HORIZON study to evaluate its oral apolipoprotein L1 (APOL1) ...
Ole Miss beat LSU in SEC play this college basketball season in a huge comeback. Sean Pedulla and Dre Davis led the Rebels to ...
Q32 Bio (QTTB) announced a corporate restructuring to focus on the advancement of its bempikibart clinical development program for the ...
4d
GlobalData on MSNQ32 Bio halts trials amid job cuts and pivots to alopecia treatmentThe company said it is evaluating its strategic options regarding ADX-097 as it shifts efforts over to pushing bempikibart.
Arrested and put before the court, the defendant, of Hawthorne Grove, Raffles, was told that he was convicted of the theft in his absence after he failed to turn up for his trial on February 3. He ...
The game is scheduled to start at 8:30 p.m. EST and will be broadcast on ABC. Fans looking to watch this NBA game can do so ...
Ole Miss beat South Carolina in SEC play this college basketball season. Malik Dia and Dre Davis had made keys plays late to propel the Rebels.
USA TODAY Sports on MSN19d
No. 2 South Carolina tops No. 18 Tennessee: Score, highlights from women's basketball gameThe Lady Vols are going to need every basket they can to get back into their game against ... the last of which carries the ...
The Phase IIa study REIMAGINE evaluated the safety and preliminary efficacy of vafidemstat in agitation/aggression in borderline personality ...
It's Auburn vs. Alabama in a matchup of the top two teams in college basketball. Follow our live game and score updates: ...
CEO Jan Mikkelsen highlighted 2024 as a pivotal year, with SKYTROFA achieving €200 million in revenue and a 6.5% share of the U.S. growth hormone market. The product now holds 45% of the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results